These culture conditions promote the expression of CD56 on CD8+ T cells and render them capable of killing cancer cells through both receptor-ligand interactions that generally mediate the cytotoxic activity of NK cells and TCR-dependent pathways resulting in direct target cell lysis. The gene discussed is NCAM1; the disease is cancer.